COOPER COMPANIES, INC.
For the period ended Oct 31, 2025. Filed Dec 5, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Dec 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on December 5, 2025.
THE COOPER COMPANIES, INC.
By: /s/ Albert G. White, III
Albert G. White, III
President & Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Albert G. White, III, Brian G. Andrews, and Daniel G. McBride, and each one of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in their name, place and stead, in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities indicated on the dates set forth opposite their respective names.
| Signature | Capacity | Date |
|---|---|---|
| /s/ ALBERT G. WHITE, III | President, Chief Executive Officer and Director (Principal Executive Officer) | December 5, 2025 |
| (Albert G. White, III) | ||
| /s/ ROBERT S. WEISS | Chairman of the Board | December 5, 2025 |
| (Robert S. Weiss) | ||
| /s/ BRIAN G. ANDREWS | Executive Vice President, Chief Financial Officer and Treasurer | December 5, 2025 |
| (Brian G. Andrews) | (Principal Financial Officer) | |
| /s/ AGOSTINO RICUPATI | Senior Vice President and Chief Accounting Officer | December 5, 2025 |
| (Agostino Ricupati) | (Principal Accounting Officer) | |
| /s/ BARBARA CARBONE | Director | December 5, 2025 |
| (Barbara Carbone) | ||
| /s/ COLLEEN E. JAY | Director | December 5, 2025 |
| (Colleen E. Jay) | ||
| /s/ CYNTHIA L. LUCCHESE | Director | December 5, 2025 |
| (Cynthia L. Lucchese) | ||
| /s/ LAWRENCE KURZIUS | Director | December 5, 2025 |
| (Lawrence Kurzius) | ||
| /s/ MARIA RIVAS M.D. | Director | December 5, 2025 |
| (Maria Rivas M.D.) | ||
| /s/ TERESA S. MADDEN | Director | December 5, 2025 |
| (Teresa S. Madden) | ||
CORPORATE INFORMATION
| BOARD OF DIRECTORSWeiss, Robert S.Chairman of the BoardCarbone, Barbara Director Jay, Colleen E.DirectorKurzius, Lawrence DirectorLucchese, Cynthia L. DirectorMadden, Teresa S. DirectorRivas, Maria, M.D.Global Chief Medical Officer for Specialty and Primary Care and Head, Evidence Generation, Pfizer, Inc.White, Albert G., IIIPresident & Chief Executive OfficerCOMMITTEES OF THE BOARDAudit CommitteeMadden, Teresa S. (Chairman)Carbone, Barbara Rivas, Maria, M.D.Corporate Governance and Nominating CommitteeLucchese, Cynthia L. (Chairman)Kurzius, LawrenceRivas, Maria, M.D. Organization and Compensation CommitteeJay, Colleen E. (Chairman)Kurzius, LawrenceLucchese, Cynthia L | EXECUTIVE OFFICERSWhite, Albert G., IIIPresident and Chief Executive OfficerMcBride, Daniel G. Executive Vice President, Chief Operating Officer, General Counsel and Corporate SecretaryAndrews, Brian G.Executive Vice President, Chief Financial Officer and TreasurerRicupati, AgostinoSenior Vice President and Chief Accounting OfficerSheffield, Holly R.President of CooperSurgical, Inc.Warner, Gerard H., IIIPresident of CooperVision, Inc.PRINCIPAL SUBSIDIARIESCooperVision, Inc.6101 Bollinger Canyon RoadSuite 500San Ramon, CA 94583925-460-3600www.coopervision.comCooperSurgical, Inc.75 Corporate DriveTrumbull, CT 06611203-601-5200www.coopersurgical.comCORPORATE OFFICESThe Cooper Companies, Inc.6101 Bollinger Canyon RoadSuite 500San Ramon, CA 94583925-460-3600www.coopercos.com | INVESTOR INFORMATIONRecent news releases, the annual report on Securities and Exchange Commission Form 10-K, information about the Company's corporate governance program, recent investor presentations, replays of quarterly conference calls and historical stock quotes are available on our website at www.coopercos.com.INVESTOR RELATIONS CONTACTKim DuncanVice President, Investor Relations and Risk Management6101 Bollinger Canyon RoadSuite 500San Ramon, CA 94583Voice: 925-460-3663E-mail: ir@cooperco.comANNUAL MEETINGThe Cooper Companies will hold its Annual Stockholders' Meeting in April 2026.TRANSFER AGENTEquiniti Trust LLC48 Wall Street, Floor 23New York, NY 10005800-937-5449TRADEMARKS CooperVision, CooperSurgical, and other trade names, trademarks or service marks of CooperCompanies and its subsidiaries appearing in this report are the property of CooperCompanies and its subsidiaries. Trade names, trademarks and service marks of the other companies appearing in this report are the property of their respective holders.INDEPENDENT AUDITORSKPMG LLPSTOCK EXCHANGE LISTINGNasdaq Global Select Market Ticker Symbol “COO” |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.